Michael Gelband’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.75M Buy
+33,683
New +$2.37M 0.02% 695
2026
Q1
Sell
-7,247
Closed -$367K 1988
2025
Q4
$367K Buy
7,247
+2,601
+56% +$133K ﹤0.01% 1261
2025
Q3
$232K Buy
+4,646
New +$213K ﹤0.01% 1353
2025
Q1
Sell
-41,827
Closed -$1.64M 1891
2024
Q4
$1.64M Buy
+41,827
New +$1.5M 0.01% 790
2023
Q4
Sell
-48,602
Closed -$1.28M 1936
2023
Q3
$1.28M Buy
48,602
+7,319
+18% +$221K 0.01% 863
2023
Q2
$1.44M Buy
41,283
+30,582
+286% +$974K 0.01% 948
2023
Q1
$355K Buy
+10,701
New +$331K ﹤0.01% 1426
2022
Q4
Sell
-30,595
Closed -$1.11M 2032
2022
Q3
$1.11M Sell
30,595
-14,493
-32% -$628K 0.01% 1064
2022
Q2
$2.16M Buy
45,088
+33,350
+284% +$1.55M 0.03% 752
2022
Q1
$621K Sell
11,738
-336
-3% -$17.7K 0.01% 1410
2021
Q4
$620K Buy
12,074
+2,401
+25% +$142K 0.01% 1283
2021
Q3
$644K Buy
+9,673
New +$756K 0.01% 1251
2020
Q4
Sell
-3,620
Closed -$469K 2304
2020
Q3
$469K Buy
+3,620
New +$476K 0.01% 1054

Other funds holding PRLB

Michael Gelband's PRLB Position: Q2 2026 in Review

Michael Gelband opened a new position in Protolabs (PRLB) in Q2 2026: 33,683 shares worth $2.75M. The stake represents 0.02% of the portfolio and ranks #695 among its holdings. This is a return to the name: Michael Gelband previously reported a position in PRLB as recently as Q4 2025.

Michael Gelband first reported a position in PRLB in Q3 2020 and has held it in 13 quarters since. 276 funds tracked by Wall St. Rank hold PRLB as of Q2 2026.

  • Michael Gelband held 33,683 shares of Protolabs worth $2.75M as of Q2 2026.
  • Protolabs was a new Michael Gelband position in Q2 2026.
  • Protolabs made up 0.02% of Michael Gelband's portfolio in Q2 2026, its #695 holding.
  • Michael Gelband first reported a position in Protolabs in Q3 2020 and has held it in 13 quarters since.
  • 276 funds tracked by Wall St. Rank held Protolabs as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.